Explore
Validate
Learn28548-1-AP
antibody from Proteintech Group
Targeting: ABCE1
OABP, RLI, RLI1, RNASEL1, RNASELI, RNS4I
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 28548-1-AP - Provider product page
- Provider
- Proteintech Group
- Product name
- ABCE1 antibody
- Antibody type
- Polyclonal
- Description
- ABCE1 antibody (Cat. #28548-1-AP) is a rabbit polyclonal antibody that shows reactivity with Human and has been validated for the following applications: IHC, WB,ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references ABCE1: A new cytoplasmic autoantibody target in systemic sclerosis-associated interstitial lung disease.
Translation stalling induced mitochondrial entrapment of ribosomal quality control related proteins offers cancer cell vulnerability.
Restoration of miR-299-3p promotes macrophage phagocytosis and suppresses malignant phenotypes in breast cancer carcinogenesis via dual-targeting CD47 and ABCE1.
CIAO1 loss of function causes a neuromuscular disorder with compromise of nucleocytoplasmic Fe-S enzymes.
Ribosome stalling during c-myc translation presents actionable cancer cell vulnerability.
Vulsteke JB, Lenaerts J, Dillaerts D, Verschueren P, Wuyts WA, De Crem N, De Sadeleer L, Vos R, De Langhe E, Bossuyt X
Autoimmunity reviews 2025 Apr 30;24(5):103764
Autoimmunity reviews 2025 Apr 30;24(5):103764
Translation stalling induced mitochondrial entrapment of ribosomal quality control related proteins offers cancer cell vulnerability.
Ojha R, Tantray I, Banerjee S, Rimal S, Thirunavukkarasu S, Srikrishna S, Chiu W, Mete U, Sharma A, Kakkar N, Lu B
Research square 2024 Sep 13;
Research square 2024 Sep 13;
Restoration of miR-299-3p promotes macrophage phagocytosis and suppresses malignant phenotypes in breast cancer carcinogenesis via dual-targeting CD47 and ABCE1.
Tong S, Zhu Y, Leng Y, Wu Y, Xiao X, Zhao W, Tan S
International immunopharmacology 2024 Mar 30;130:111708
International immunopharmacology 2024 Mar 30;130:111708
CIAO1 loss of function causes a neuromuscular disorder with compromise of nucleocytoplasmic Fe-S enzymes.
Maio N, Orbach R, Zaharieva IT, Töpf A, Donkervoort S, Munot P, Mueller J, Willis T, Verma S, Peric S, Krishnakumar D, Sudhakar S, Foley AR, Silverstein S, Douglas G, Pais L, DiTroia S, Grunseich C, Hu Y, Sewry C, Sarkozy A, Straub V, Muntoni F, Rouault TA, Bönnemann CG
The Journal of clinical investigation 2024 Jun 17;134(12)
The Journal of clinical investigation 2024 Jun 17;134(12)
Ribosome stalling during c-myc translation presents actionable cancer cell vulnerability.
Khaket TP, Rimal S, Wang X, Bhurtel S, Wu YC, Lu B
PNAS nexus 2024 Aug;3(8):pgae321
PNAS nexus 2024 Aug;3(8):pgae321
No comments: Submit comment
No validations: Submit validation data